Zoetis

Zoetis jumped more than 6% in Thursday morning trading as leaders of the animal-health company reiterated their confidence in the safety of an arthritis drug fo...

Why Zoetis, Fluffy's Drugmaker, Just Reversed Its Recent Bad Fortune...

Loading... Loading... Zoetis Inc ZTS shares are trading higher after the company reported first-quarter FY24 revenue of $2.19 billion, up 10% Y/Y on reported a...

Reported Revenue: $2.2 billion, an increase of 10% year-over-year. Net Income: $599 million, marking a 9% increase year-over-year. Diluted EPS: Reported at $1...

Zoetis (ZTS) came out with quarterly earnings of $1.38 per share, beating the Zacks Consensus Estimate of $1.34 per share. This compares to earnings of $1.31 pe...

May 2 (Reuters) - Animal healthcare company Zoetis surpassed analysts' expectations for first-quarter profit on Thursday, helped by strong demand for its medici...

Zoetis (ZTS) stock rose modestly early Thursday after the pet drugmaker reported adjusted earnings of $1.38 per share on $2.19 billion in first-quarter sales....

Reports Revenue of $2.2 Billion, Growing 10%, and Net Income of $599 Million, or $1.31 per Diluted Share, Increasing 9% and 10%, Respectively, on a Reported Bas...

Loading... Loading... Financial giants have made a conspicuous bearish move on Zoetis. Our analysis of options history for Zoetis ZTS revealed 10 unusual trade...

Stifel lowered the firm’s price target on Zoetis to $180 from $195 and keeps a Buy rating on the shares. The firm believes Q1 top-line will modestly exceed cons...